Metavesco, Inc. (OTC PINK: MVCO) announced the launch of OTC Squawk, a social network purpose-built for the over-the-counter (OTC) market. The platform, now in closed beta, provides a dedicated space for ticker-level research, due diligence, and real-time conversation, addressing the fragmentation OTC traders have long experienced on general-purpose platforms.
Each supported OTC symbol gets its own page featuring price data, day range and volume, price history, OTC tier and sector, a direct link to SEC EDGAR filings, top contributors, and live discussion. Traders can post in three formats: quick Squawks, Threads, and full Due Diligence write-ups that are displayed natively on the ticker page. Every post can be tagged as bullish or bearish.
A key feature is Motion, a publicly displayed reputation score earned through consistent, high-quality participation. This allows members to easily identify who is producing the most respected research in any given name. Transparency is built in: the exact formulas behind how feeds rank are published on the platform's “How it works” page, and default feeds cannot be bought—there is no pay-to-rank.
OTC Squawk consolidates ticker pages, long-form due diligence, market data, live discussion, and earned, transparent reputation into one platform. Additionally, an open feedback channel allows users to contribute feature ideas that shape the platform's future.
Alongside the launch, OTC Squawk is opening applications for Ambassadors—a cohort of creators, traders, and community leaders in the OTC market who will help build the platform from its earliest days. Creators covering the OTC market can apply through their account at otcsquawk.com/ambassador.
Access during beta is invite-only. Traders can join the waitlist and reserve their @handle now at otcsquawk.com.
Separately, the company said it expects to file its quarterly report for the quarter ended March 31, 2026 in the next ten business days and noted work on the annual report for the year ending June 30, 2026 is already underway.
Metavesco, Inc. is a publicly traded holding company focused on building infrastructure and opportunity for the OTC market. The company operates with a long-term, co-owner-aligned philosophy and is committed to supporting the strength, transparency, and integrity of the OTC market.
